α-Bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell lineQUIK, M; CHAN, J; PATRICK, J et al.Brain research. 1994, Vol 655, Num 1-2, pp 161-167, issn 0006-8993Article

Improved flow-cytometric detection of low P-glycoprotein expression in leukaemic blasts by histogram subtraction analysisMÜLLER, M. R; LENNARTZ, K; NOWROUSIAN, M. R et al.Cytometry (New York, N.Y.). 1994, Vol 15, Num 1, pp 64-72, issn 0196-4763Article

Factors regulating the production of vasopressin-associated human neurophysin by small-cell carcinoma of the lung : evaluation by computer-enhanced quantitative immunocytochemistryFRIEDMANN, A. S; FAY, M. J; MEMOLI, V. A et al.Neuropeptides (Edinburgh). 1995, Vol 28, Num 3, pp 183-189, issn 0143-4179Article

Characterization of the M_r 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cellsALMQUIST, K. C; LOE, D. W; HIPFNER, D. R et al.Cancer research (Baltimore). 1995, Vol 55, Num 1, pp 102-110, issn 0008-5472Article

Genetic alterations and expression of the protein phosphatase 1 genes in human cancersTAKAKURA, Satoshi; KOHNO, Takashi; MANDA, Ryokuhei et al.International journal of oncology. 2001, Vol 18, Num 4, pp 817-824, issn 1019-6439Article

Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line : evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase IICOLE, S. P. C; CHANDA, E. R; DICKE, F. P et al.Cancer research (Baltimore). 1991, Vol 51, Num 13, pp 3345-3352, issn 0008-5472, 8 p.Article

Transforming growth factor-β inhibition of proteasomal activity: a potential mechanism of growth arrestTADLOCK, Laura; YAMAGIWA, Yoko; HAWKER, James et al.American journal of physiology. Cell physiology. 2003, Vol 54, Num 2, pp C277-C285, issn 0363-6143Article

Development and validation of a spectrophotometric assay for measuring the activity of NADH : cytochrome b₅ reductase in human tumour cellsBARHAM, H. M; INGLIS, R; CHINJE, E. C et al.British journal of cancer. 1996, Vol 74, Num 8, pp 1188-1193, issn 0007-0920Article

Reversal of adriamycin resistance with chimeric anti-ganglioside G_M2 antibodyFUKUMOTO, H; NISHIO, K; OHTA, S et al.International journal of cancer. 1996, Vol 67, Num 5, pp 676-680, issn 0020-7136Article

Cytolotic activity of natural killer and lymphokine-activated killer cells against human tumor cell lines resistant to chemotherapeutic agentsMIURA, K; NISHIO, K; HEIKE, Y et al.The Cancer journal (Print). 1993, Vol 6, Num 2, pp 91-96, issn 0765-7846Article

Processing of the neuropeptide growth factor antagonist [Arg⁶, D-Trp^7,9, NmePHE⁸]-substance P (6-11) by a small cell lung cancer cell line (H69)CUMMINGS, J; MACLELLAN, A. J; LANGDON, S. P et al.Biochemical pharmacology. 1995, Vol 49, Num 11, pp 1709-1712, issn 0006-2952Article

Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatinKASAHARA, K; FUJIWARA, Y; NISHIO, K et al.Cancer research (Baltimore). 1991, Vol 51, Num 12, pp 3237-3242, issn 0008-5472, 6 p.Article

Flow cytometric analysis of Hoechst 33342 uptake as an indicator of multi-drug resistance in human lung cancerMORGAN, S. A; WATSON, J. V; TWENTYMAN, P. R et al.British journal of cancer. 1989, Vol 60, Num 3, pp 282-287, issn 0007-0920Article

Characterization of an etoposide-resistant human small-cell lung cancer cell lineMINATO, K; KANZAWA, F; NISHIO, K et al.Cancer chemotherapy and pharmacology. 1990, Vol 26, Num 5, pp 313-317, issn 0344-5704, 5 p.Article

Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cellsBROCK, I; HIPFNER, D. R; NIELSEN, B. S et al.Cancer research (Baltimore). 1995, Vol 55, Num 3, pp 459-462, issn 0008-5472Article

Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazolesDUAN, Jian-Xin; XIAOHONG CAI; FANYING MENG et al.Journal of medicinal chemistry (Print). 2007, Vol 50, Num 5, pp 1001-1006, issn 0022-2623, 6 p.Article

QSAR studies about cytotoxicity of benzophenazines with dual inhibition toward both topoisomerases I and II: 3D-MoRSE descriptors and statistical considerations about variable selectionSAIZ-URRA, Liane; PEREZ GONZALEZ, Maykel; TEIJEIRA, Marta et al.Bioorganic & medicinal chemistry. 2006, Vol 14, Num 21, pp 7347-7358, issn 0968-0896, 12 p.Article

Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublinesTSURUTANI, Junji; SODA, Hiroshi; KOHNO, Shigeru et al.International journal of cancer. 2003, Vol 104, Num 2, pp 238-242, issn 0020-7136, 5 p.Article

Combined therapy of multidrug-resistant human lung cancer with anti-P-glycoprotein antibody and monocyte chemoattractant protein- gene transduction: The possibility of immunological overcoming of multidrug resistanceNISHIOKA, Y; YANO, S; FUJIKI, F et al.International journal of cancer. 1997, Vol 71, Num 2, pp 170-177, issn 0020-7136Article

Effect of endogenous and exogenous EGF on the growth of EGF receptor-hyperproducing human squamous cell carcinoma implanted in nude miceKITAGAWA, Y; UEDA, M; ANDO, N et al.British journal of cancer. 1995, Vol 72, Num 4, pp 865-868, issn 0007-0920Article

A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP geneBARRAND, M. A; HEPPELL-PARTON, A. C; WRIGHT, K. A et al.Journal of the National Cancer Institute. 1994, Vol 86, Num 2, pp 110-117, issn 0027-8874Article

Characterization of a taxol-resistant human small-cell lung cancer cell lineOHTA, S; NISHIO, K; KUBOTA, N et al.Japanese journal of cancer research. 1994, Vol 85, Num 3, pp 290-297, issn 0910-5050Article

Potentiation of long-term-cultured lymphokine-activated killer cell cytotoxicity against small-cell lung carcinoma by anti-CD3 × anti-(tumor-associated antigen) bispecific antibodyAZUMA, A; YAGITA, H; OKUMURA, K et al.Cancer immunology and immunotherapy. 1994, Vol 38, Num 5, pp 294-298, issn 0340-7004Article

Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg⁶, D-Trp^7,9, N^meOhe⁸]-substance P (6-11)-induced growth inhibitionWATERS, C. M; MACKINNON, A. C; CUMMINGS, J et al.British journal of cancer. 2003, Vol 88, Num 11, pp 1808-1816, issn 0007-0920, 9 p.Article

Suppression of tumor growth by growth hormone-releasing hormone antagonist JV-1-36 does not involve the inhibition of autocrine production of insulin-like growth factor II in H-69 small cell lung carcinomaKIARIS, Hippokratis; SCHALLY, Andrew V; VARGA, Jozsef L et al.Cancer letters. 2000, Vol 161, Num 2, pp 149-155, issn 0304-3835Article